Cited by 139

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation

Matikainen-Ankney, B. A., Kezunovic, N., Mesias, R. E., Tian, Y., Williams, F. M., Huntley, G. W., Benson, D. L.·2016·Journal of Neuroscience

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3314-15.2016

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 15 references

Research works printed but not linked: 91

  1. Andreae LC, Fredj NB, Burrone J (2012) Independent vesicle pools underlie different modes of release during neuronal development. J Neurosci 32: 1867-1874. CrossRef Medline · DOI
  2. Archer T, Garcia D (2015) Attention-deficit/hyperactivity disorder: focus upon aberrant N-methyl-D-aspartate receptors systems. Curr Top Behav Neurosci. Advance online publication. Retrieved June 1, 2015. doi: 10.1007/7854_2015_415. CrossRef Medline · DOI
  3. Arranz AM, Delbroek L, Van Kolen K, Guimara ˜es MR, Mandemakers W, Daneels G, Matta S, Calafate S, Shaban H, Baatsen P, De Bock PJ, Gevaert K, Vanden Berghe P, Verstreken P, De Strooper B, Moechars D (2015) LRRK2 functions in synaptic vesicle endocytosis through a kinase- dependent mechanism. J Cell Sci 128:541-552. CrossRef Medline · DOI · Paper page
  4. Atasoy D, Ertunc M, Moulder KL, Blackwell J, Chung C, Su J, Kavalali ET (2008) Spontaneous and evoked glutamate release activates two popula- tions of NMDA receptors with limited overlap. J Neurosci 28:10151- 10166. CrossRef Medline · DOI
  5. Bal M, Leitz J, Reese AL, Ramirez DM, Durakoglugil M, Herz J, Monteggia LM, Kavalali ET (2013) Reelin mobilizes a VAMP7-dependent synaptic vesicle pool and selectively augments spontaneous neurotransmission. Neuron 80:934 -946. CrossRef Medline · DOI · Paper page
  6. Beccano-Kelly DA, Kuhlmann N, Tatarnikov I, Volta M, Munsie LN, Chou P, Cao LP, Han H, Tapia L, Farrer MJ, Milnerwood AJ (2014) Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice. Front Cell Neurosci 8:301. CrossRef Medline · DOI · Paper page
  7. Beccano-Kelly DA, Volta M, Munsie LN, Paschall SA, Tatarnikov I, Co K, Chou P, Cao LP, Bergeron S, Mitchell E, Han H, Melrose HL, Tapia L, Raymond LA, Farrer MJ, Milnerwood AJ (2015) LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, post- synaptic signal transduction, motor activity and memory. Hum Mol Genet 24:1336 -1349. CrossRef Medline · DOI · Paper page
  8. Belluzzi E, Gonnelli A, Cirnaru MD, Marte A, Plotegher N, Russo I, Civiero L, Cogo S, Carrion MP, Franchin C, Arrigoni G, Beltramini M, Bubacco L, Onofri F, Piccoli G, Greggio E (2016) LRRK2 phosphorylates pre- synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate. Mol Neurode- gener 11:1. CrossRef Medline · DOI · Paper page
  9. Biskup S, Moore DJ, Rea A, Lorenz-Deperieux B, Coombes CE, Dawson VL, Dawson TM, West AB (2007) Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC Neurosci 8:102. CrossRef Medline · DOI
  10. Centonze D, Usiello A, Costa C, Picconi B, Erbs E, Bernardi G, Borrelli E, Calabresi P (2004) Chronic haloperidol promotes corticostriatal long- term potentiation by targeting dopamine D 2 L receptors. J Neurosci 24: 8214 -8222. CrossRef Medline · DOI
  11. Cookson MR (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci 11:791-797. CrossRef Medline · DOI
  12. Da ¨chsel JC, Behrouz B, Yue M, Beevers JE, Melrose HL, Farrer MJ (2010) A comparative study of Lrrk2 function in primary neuronal cultures. Par- kinsonism Relat Disord 16:650 -655. CrossRef Medline · DOI
  13. Davies P, Hinkle KM, Sukar NN, Sepulveda B, Mesias R, Serrano G, Alessi DR, Beach TG, Benson DL, White CL, Cowell RM, Das SS, West AB, Melrose HL (2013) Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies. Biochem J 453:101-113. CrossRef Medline · DOI
  14. Di Fonzo A, Rohe ´CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N, Goldwurm S, Breedveld G, Sampaio C, Meco G, Barbosa E, Oostra BA, Bonifati V (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365:412-415. CrossRef Medline · DOI · Paper page
  15. Dong Y, Green T, Saal D, Marie H, Neve R, Nestler EJ, Malenka RC (2006) CREB modulates excitability of nucleus accumbens neurons. Nat Neuro- sci 9:475-477. CrossRef Medline · DOI
  16. Ehlers CL, Criado JR (2010) Adolescent ethanol exposure: does it produce long-lasting electrophysiological effects? Alcohol 44:27-37. CrossRef Medline · DOI
  17. Erro R, Santangelo G, Picillo M, Vitale C, Amboni M, Longo K, Costagliola A, Pellecchia MT, Allocca R, De Rosa A, De Michele G, Santoro L, Barone P (2012) Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. J Neurol 259:1808 -1813. CrossRef Medline · DOI
  18. Estrada AA, Liu X, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Chan BK, Chen H, Ding X, DiPasquale AG, Dominguez SL, Dotson J, Drummond J, Flagella M, Flynn S, Fuji R, Gill A, Gunzner-Toste J, Harris SF, Heffron TP, Kleinheinz T, et al. (2012) Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem 55:9416 -9433. CrossRef Medline · DOI
  19. Feliciano P, Andrade R, Bykhovskaia M (2013) Synapsin II and Rab3a co- operate in the regulation of epileptic and synaptic activity in the CA1 region of the hippocampus. J Neurosci 33:18319 -18330. CrossRef Medline · DOI
  20. Fino E, Glowinski J, Venance L (2007) Effects of acute dopamine depletion on the electrophysiological properties of striatal neurons. Neurosci Res 58:305-316. CrossRef Medline · DOI
  21. Friedman LG, Riemslagh FW, Sullivan JM, Mesias R, Williams FM, Huntley GW, Benson DL (2015) Cadherin-8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal cir- cuits. J Comp Neurol 523:75-92. CrossRef Medline · DOI
  22. Fujiyama F, Kuramoto E, Okamoto K, Hioki H, Furuta T, Zhou L, Nomura S, Kaneko T (2004) Presynaptic localization of an AMPA-type glutamate receptor in corticostriatal and thalamostriatal axon terminals. Eur J Neu- rosci 20:3322-3330. CrossRef Medline · DOI
  23. Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133-139. CrossRef Medline · DOI
  24. Gerfen CR, Surmeier DJ (2011) Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34:441-466. CrossRef Medline · DOI
  25. Giesert F, Hofmann A, Bu ¨rger A, Zerle J, Kloos K, Hafen U, Ernst L, Zhang J, Vogt-Weisenhorn DM, Wurst W (2013) Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice. PLoS One 8:e63778. CrossRef Medline · DOI
  26. Glodowski DR, Chen CC, Schaefer H, Grant BD, Rongo C (2007) RAB-10 regulates glutamate receptor recycling in a cholesterol-dependent endo- cytosis pathway. Mol Biol Cell 18:4387-4396. CrossRef Medline · DOI · Paper page
  27. Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, van der Brug MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, Cookson MR (2006) Kinase activity is required for the toxic effects of mutant LRRK2/ dardarin. Neurobiol Dis 23:329 -341. CrossRef Medline · DOI · Paper page
  28. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neu- rol 7:583-590. CrossRef Medline · DOI · Paper page
  29. Helmich RC, Thaler A, van Nuenen BF, Gurevich T, Mirelman A, Marder KS, Bressman S, Orr-Urtreger A, Giladi N, Bloem BR, Toni I (2015) Reor- ganization of corticostriatal circuits in healthy G2019S LRRK2 carriers. Neurology 84:399 -406. CrossRef Medline · DOI
  30. Herzig MC, Kolly C, Persohn E, Theil D, Schweizer T, Hafner T, Stemmelen C, Troxler TJ, Schmid P, Danner S, Schnell CR, Mueller M, Kinzel B, Grevot A, Bolognani F, Stirn M, Kuhn RR, Kaupmann K, van der Putten PH, Rovelli G, Shimshek DR (2011) LRRK2 protein levels are deter- mined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet 20:4209 -4223. CrossRef Medline · DOI
  31. Ito G, Fujimoto T, Kamikawaji S, Kuwahara T, Iwatsubo T (2014) Lack of correlation between the kinase activity of LRRK2 harboring kinase- modifying mutations and its phosphorylation at Ser910, 935, and Ser955. PLoS One 9:e97988. CrossRef Medline · DOI
  32. Jaleel M, Nichols RJ, Deak M, Campbell DG, Gillardon F, Knebel A, Alessi DR (2007) LRRK2 phosphorylates moesin at threonine-558: characteriza- tion of how Parkinson's disease mutants affect kinase activity. Biochem J 405:307-317. CrossRef Medline · DOI · Paper page
  33. Johnson LN, Noble ME, Owen DJ (1996) Active and inactive protein ki- nases: structural basis for regulation. Cell 85:149 -158. CrossRef Medline · DOI
  34. Khan NL, Jain S, Lynch JM, Pavese N, Abou-Sleiman P, Holton JL, Healy DG, Gilks WP, Sweeney MG, Ganguly M, Gibbons V, Gandhi S, Vaughan J, Eunson LH, Katzenschlager R, Gayton J, Lennox G, Revesz T, Nicholl D, Bhatia KP, et al. (2005) Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfac- tory and functional imaging and genetic data. Brain 128:2786 -2796. CrossRef Medline · DOI
  35. Kreitzer AC, Malenka RC (2008) Striatal plasticity and basal ganglia circuit function. Neuron 60:543-554. CrossRef Medline · DOI
  36. Lee H, Melrose HL, Yue M, Pare JF, Farrer MJ, Smith Y (2010a) Lrrk2 lo- calization in the primate basal ganglia and thalamus: a light and electron microscopic analysis in monkeys. Exp Neurol 224:438 -447. CrossRef Medline · DOI
  37. Lee S, Liu HP, Lin WY, Guo H, Lu B (2010b) LRRK2 kinase regulates syn- aptic morphology through distinct substrates at the presynaptic and post- synaptic compartments of the Drosophila neuromuscular junction. J Neurosci 30:16959 -16969. CrossRef Medline · DOI
  38. Li X, Patel JC, Wang J, Avshalumov MV, Nicholson C, Buxbaum JD, Elder GA, Rice ME, Yue Z (2010) Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J Neurosci 30:1788 - 1797. CrossRef Medline · DOI
  39. Liu M, Kang S, Ray S, Jackson J, Zaitsev AD, Gerber SA, Cuny GD, Glicksman MA (2011) Kinetic, mechanistic, and structural modeling studies of truncated wild-type leucine-rich repeat kinase 2 and the G2019S mutant. Biochemistry 50:9399 -9408. CrossRef Medline · DOI
  40. MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A (2006) The familial Parkinsonism gene LRRK2 regulates neurite process mor- phology. Neuron 52:587-593. CrossRef Medline · DOI
  41. Matta S, Van Kolen K, da Cunha R, van den Bogaart G, Mandemakers W, Miskiewicz K, De Bock PJ, Morais VA, Vilain S, Haddad D, Delbroek L, Swerts J, Cha ´vez-Gutie ´rrez L, Esposito G, Daneels G, Karran E, Holt M, Gevaert K, Moechars DW, De Strooper B, Verstreken P, et al. (2012) LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron 75:1008 -1021. CrossRef Medline · DOI · Paper page
  42. Meixner A, Boldt K, Van Troys M, Askenazi M, Gloeckner CJ, Bauer M, Marto JA, Ampe C, Kinkl N, Ueffing M (2011) A QUICK screen for Lrrk2 interaction partners-leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics. Mol Cell Proteomics 10:M110.001172. CrossRef Medline · DOI
  43. Molero AE, Arteaga-Bracho EE, Chen CH, Gulinello M, Winchester ML, Pichamoorthy N, Gokhan S, Khodakhah K, Mehler MF (2016) Selective expression of mutant huntingtin during development recapitulates char- acteristic features of Huntington's disease. Proc Natl Acad Sci U S A 113: 5736 -5741. CrossRef Medline · DOI
  44. Nichols RJ, Dzamko N, Hutti JE, Cantley LC, Deak M, Moran J, Bamborough P, Reith AD, Alessi DR (2009) Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem J 424: 47-60. CrossRef Medline · DOI
  45. Nichols RJ, Dzamko N, Morrice NA, Campbell DG, Deak M, Ordureau A, Macartney T, Tong Y, Shen J, Prescott AR, Alessi DR (2010) 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochem J 430:393- 404. CrossRef Medline · DOI
  46. Nikitczuk JS, Patil SB, Matikainen-Ankney BA, Scarpa J, Shapiro ML, Benson DL, Huntley GW (2014) N-cadherin regulates molecular organization of excitatory and inhibitory synaptic circuits in adult hippocampus in vivo. Hippocampus 24:943-962. CrossRef Medline · DOI
  47. Nolen B, Taylor S, Ghosh G (2004) Regulation of protein kinases; control- ling activity through activation segment conformation. Mol Cell 15:661- 675. CrossRef Medline · DOI
  48. Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354:424 -425. CrossRef Medline · DOI
  49. Paisa ´n-Ruiz C, Jain S, Evans EW, Gilks WP, Simo ´n J, van der Brug M, Lo ´pez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Martí-Masso ´JF, Pe ´rez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene con- taining mutations that cause PARK8-linked Parkinson's disease. Neuron 44:595-600. CrossRef Medline · DOI
  50. Paisa ´n-Ruiz C, Lewis PA, Singleton AB (2013) LRRK2: cause, risk, and mechanism. J Parkinsons Dis 3:85-103. CrossRef Medline · DOI
  51. Parisiadou L, Xie C, Cho HJ, Lin X, Gu XL, Long CX, Lobbestael E, Baeke- landt V, Taymans JM, Sun L, Cai H (2009) Phosphorylation of ezrin/ radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 29:13971-13980. CrossRef Medline · DOI
  52. Parisiadou L, Yu J, Sgobio C, Xie C, Liu G, Sun L, Gu XL, Lin X, Crowley NA, Lovinger DM, Cai H (2014) LRRK2 regulates synaptogenesis and dopa- mine receptor activation through modulation of PKA activity. Nat Neu- rosci 17:367-376. CrossRef Medline · DOI
  53. Pavlos NJ, Grønborg M, Riedel D, Chua JJ, Boyken J, Kloepper TH, Urlaub H, Rizzoli SO, Jahn R (2010) Quantitative analysis of synaptic vesicle Rabs uncovers distinct yet overlapping roles for Rab3a and Rab27b in Ca 2ϩ - triggered exocytosis. J Neurosci 30:13441-13453. CrossRef Medline · DOI
  54. Peixoto RT, Wang W, Croney DM, Kozorovitskiy Y, Sabatini BL (2016) Early hyperactivity and precocious maturation of corticostriatal circuits in Shank3B(Ϫ/Ϫ) mice. Nat Neurosci 19:716 -724. CrossRef Medline · DOI
  55. Piccoli G, Condliffe SB, Bauer M, Giesert F, Boldt K, De Astis S, Meixner A, Sarioglu H, Vogt-Weisenhorn DM, Wurst W, Gloeckner CJ, Matteoli M, Sala C, Ueffing M (2011) LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J Neurosci 31:2225-2237. CrossRef Medline · DOI
  56. Piccoli G, Onofri F, Cirnaru MD, Kaiser CJ, Jagtap P, Kastenmu ¨ller A, Pisch- edda F, Marte A, von Zweydorf F, Vogt A, Giesert F, Pan L, Antonucci F, Kiel C, Zhang M, Weinkauf S, Sattler M, Sala C, Matteoli M, Ueffing M, Gloeckner CJ (2014) Leucine-rich repeat kinase 2 binds to neuronal ves- icles through protein interactions mediated by its C-terminal WD40 do- main. Mol Cell Biol 34:2147-2161. CrossRef Medline · DOI · Paper page
  57. Raju DV, Shah DJ, Wright TM, Hall RA, Smith Y (2006) Differential synap- tology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol 499:231-243. CrossRef Medline · DOI
  58. Ray S, Liu M (2012) Current understanding of LRRK2 in Parkinson's dis- ease: biochemical and structural features and inhibitor design. Future Med Chem 4:1701-1713. CrossRef Medline · DOI
  59. Rodriguez A, Ehlenberger DB, Hof PR, Wearne SL (2006) Rayburst sam- pling, an algorithm for automated three-dimensional shape analysis from laser scanning microscopy images. Nat Protoc 1:2152-2161. CrossRef Medline · DOI
  60. Sakaguchi-Nakashima A, Meir JY, Jin Y, Matsumoto K, Hisamoto N (2007) LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic po- larity of SV proteins. Curr Biol 17:592-598. CrossRef Medline · DOI
  61. Sara Y, Virmani T, Dea ´k F, Liu X, Kavalali ET (2005) An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission. Neu- ron 45:563-573. CrossRef Medline · DOI
  62. Sepulveda B, Mesias R, Li X, Yue Z, Benson DL (2013) Short-and long-term effects of LRRK2 on axon and dendrite growth. PLoS One 8:e61986. CrossRef Medline · DOI
  63. Sharpe NA, Tepper JM (1998) Postnatal development of excitatory synaptic input to the rat neostriatum: an electron microscopic study. Neuroscience 84:1163-1175. CrossRef Medline · DOI
  64. Shepherd GM (2013) Corticostriatal connectivity and its role in disease. Nat Rev Neurosci 14:278 -291. CrossRef Medline · DOI · Paper page
  65. Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K, Mali- now R (1999) Rapid spine delivery and redistribution of AMPA recep- tors after synaptic NMDA receptor activation. Science 284:1811-1816. CrossRef Medline · DOI · Paper page
  66. Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2000) Anxiety disorders and depressive dis- orders preceding Parkinson's disease: a case-control study. Mov Disord 15:669 -677. CrossRef Medline · DOI · Paper page
  67. Shin N, Jeong H, Kwon J, Heo HY, Kwon JJ, Yun HJ, Kim CH, Han BS, Tong Y, Shen J, Hatano T, Hattori N, Kim KS, Chang S, Seol W (2008) LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res 314:2055-2065. CrossRef Medline · DOI
  68. Skibinski G, Nakamura K, Cookson MR, Finkbeiner S (2014) Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J Neurosci 34:418 -433. CrossRef Medline · DOI
  69. Smeal RM, Gaspar RC, Keefe KA, Wilcox KS (2007) A rat brain slice prep- aration for characterizing both thalamostriatal and corticostriatal affer- ents. J Neurosci Methods 159:224 -235. CrossRef Medline · DOI
  70. Sohur US, Padmanabhan HK, Kotchetkov IS, Menezes JR, Macklis JD (2014) Anatomic and molecular development of corticostriatal projection neu- rons in mice. Cereb Cortex 24:293-303. CrossRef Medline · DOI
  71. Steger M, Tonelli F, Ito G, Davies P, Trost M, Vetter M, Wachter S, Lorentzen E, Duddy G, Wilson S, Baptista MA, Fiske BK, Fell MJ, Morrow JA, Reith AD, Alessi DR, Mann M (2016) Phosphoproteomics reveals that Par- kinson's disease kinase LRRK2 regulates a subset of Rab GTPases. Elife 5. CrossRef · DOI · Paper page
  72. Sutton MA, Ito HT, Cressy P, Kempf C, Woo JC, Schuman EM (2006) Min- iature neurotransmission stabilizes synaptic function via tonic suppres- sion of local dendritic protein synthesis. Cell 125:785-799. CrossRef Medline · DOI · Paper page
  73. Sutton MA, Taylor AM, Ito HT, Pham A, Schuman EM (2007) Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling min- iature synaptic transmission to local protein synthesis. Neuron 55:648 - 661. CrossRef Medline · DOI · Paper page
  74. Sweet ES, Saunier-Rebori B, Yue Z, Blitzer RD (2015) The Parkinson's disease-associated mutation LRRK2-G2019S impairs synaptic plasticity in mouse hippocampus. J Neurosci 35:11190 -11195. CrossRef Medline · DOI
  75. Taylor JP, Mata IF, Farrer MJ (2006) LRRK2: a common pathway for par- kinsonism, pathogenesis and prevention? Trends Mol Med 12:76 -82. CrossRef Medline · DOI
  76. Taymans JM, Van den Haute C, Baekelandt V (2006) Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem 98:951-961. CrossRef Medline · DOI
  77. Tepper JM, Sharpe NA, Koo ´s TZ, Trent F (1998) Postnatal development of the rat neostriatum: electrophysiological, light-and electron-microscopic studies. Dev Neurosci 20:125-145. CrossRef Medline · DOI
  78. Thaler A, Mirelman A, Helmich RC, van Nuenen BF, Rosenberg-Katz K, Gurevich T, Orr-Urtreger A, Marder K, Bressman S, Bloem BR, Giladi N, Hendler T (2013) Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers. Cortex 49:2501-2511. CrossRef Medline · DOI
  79. Thaler A, Helmich RC, Or-Borichev A, van Nuenen BF, Shapira-Lichter I, Gurevich T, Orr-Urtreger A, Marder K, Bressman S, Bloem BR, Giladi N, Hendler T, Mirelman A (2016) Intact working memory in non- manifesting LRRK2 carriers-an fMRI study. Eur J Neurosci 43:106 -112. CrossRef Medline · DOI
  80. Turrigiano GG (2008) The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135:422-435. CrossRef Medline · DOI · Paper page
  81. Vercelli A, Marini G, Tredici G (2003) Anatomical organization of the tel- encephalic connections of the parafascicular nucleus in adult and devel- oping rats. Eur J Neurosci 18:275-289. CrossRef Medline · DOI
  82. West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102:16842-16847. CrossRef Medline · DOI · Paper page
  83. West AB, Cowell RM, Daher JP, Moehle MS, Hinkle KM, Melrose HL, Stan- daert DG, Volpicelli-Daley LA (2014) Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents. J Comp Neurol 522:2465-2480. CrossRef Medline · DOI · Paper page
  84. Westerlund M, Belin AC, Anvret A, Bickford P, Olson L, Galter D (2008) Developmental regulation of leucine-rich repeat kinase 1 and 2 expres- sion in the brain and other rodent and human organs: implications for Parkinson's disease. Neuroscience 152:429 -436. CrossRef Medline · DOI
  85. Winner B, Melrose HL, Zhao C, Hinkle KM, Yue M, Kent C, Braithwaite AT, Ogholikhan S, Aigner R, Winkler J, Farrer MJ, Gage FH (2011) Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice. Neurobiol Dis 41:706 -716. CrossRef Medline · DOI
  86. Wise SP, Jones EG (1977) Cells of origin and terminal distribution of de- scending projections of the rat somatic sensory cortex. J Comp Neurol 175:129 -157. CrossRef Medline · DOI
  87. Yun HJ, Park J, Ho DH, Kim H, Kim CH, Oh H, Ga I, Seo H, Chang S, Son I, Seol W (2013) LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25. Exp Mol Med 45:e36. CrossRef Medline · DOI
  88. Yuste R, Bonhoeffer T (2001) Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 24: 1071-1089. CrossRef Medline · DOI · Paper page
  89. Yuste R, Bonhoeffer T (2004) Genesis of dendritic spines: insights from ul- trastructural and imaging studies. Nat Rev Neurosci 5:24 -34. CrossRef Medline · DOI
  90. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carba- jal IC, Vieregge P, Asmus F, Mu ¨ller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neu- ron 44:601-607. CrossRef Medline · DOI
  91. Zito K, Knott G, Shepherd GM, Shenolikar S, Svoboda K (2004) Induction of spine growth and synapse formation by regulation of the spine actin cytoskeleton. Neuron 44:321-334. CrossRef Medline · DOI

Cited by

Sorted by citations

See all 139

Metadata

Authors
Matikainen-Ankney, B. A., Kezunovic, N., Mesias, R. E., Tian, Y., Williams, F. M., Huntley, G. W., & Benson, D. L.
Venue
Journal of Neuroscience
Published
2016-07-06
Volume
36
Issue
27
Pages
7128-7141
ISSN
  • 0270-6474
  • 1529-2401
Cited by
139
References
15
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review